US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 1.630
  • +0.060+3.82%
Close Jan 17 16:00 ET
  • 1.600
  • -0.030-1.84%
Post 19:32 ET
247.91MMarket Cap-10.19P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Heron Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 37.367M--
Nov 12, 20242024/Q332.810M / 36.933M--
Aug 6, 20242024/Q236.024M / 35.888M--
May 7, 20242024/Q134.670M / 32.975M--
Mar 12, 20242023/Q434.233M / 31.217M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 37.367M--
Nov 12, 20242024/Q332.810M / 36.933M--
Aug 6, 20242024/Q236.024M / 35.888M--
May 7, 20242024/Q134.670M / 32.975M--
Mar 12, 20242023/Q434.233M / 31.217M--

Unlock Free Earnings Estimates

Heron Therapeutics Earnings Reports

  • Heron Therapeutics | 8-K: Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance

    Nov 12, 2024 09:40 ET

  • Heron Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 09:34 ET

  • Heron Therapeutics | 8-K: Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance

    Aug 6, 2024 16:10 ET

  • Heron Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data